The Ozempic Epidemic
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have exploded in popularity for weight loss and diabetes management. But behind the dramatic before-and-after photos lie serious risks that every patient needs to know. In this video, we break down the real dangers of GLP-1s.

▶︎
The Dark Side Of Ozempic Nobody Talks About

▶︎
Silicon Valley's new miracle drug

▶︎
I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.

▶︎
The New Face of America: Inside the Second Great Depression

▶︎
Ozempic Changed Everything… But Nobody Talks About What Happens After

▶︎
Ozempic & Mounjaro: Same Shot. Opposite Results.

▶︎
I Investigated The World's Skinniest vs Fattest City

▶︎
"Doom Trolling:" Why AI Leaders Are Stoking Fear About Their On Tech | Amanpour and Company

▶︎
GLP-1s Are a Lot Weirder Than Anyone Thought | The Ezra Klein Show

▶︎
10 Hidden Social Rules in Germany Nobody Warns You About!

▶︎
I'm a Pathologist. Ozempic & Mounjaro Aren't Actually Weight Loss Drugs.

▶︎
This Ozempic Discovery Has Cardiologists Stunned

▶︎
Jillian Michaels vs The Body Positivity Movement | Surrounded

▶︎
What's REALLY Happening in Russia Right Now?

▶︎
Eli Lilly CEO: How GLP-1s Will Reshape America

▶︎
HRT, misinformation and navigating the menopause media minefield with Kaye Adams

▶︎
Oprah and Yale Researcher Break Down How Weight Loss Drugs Affect the Brain

▶︎
Doctor Explains How to Dose Retatrutide to MAXIMIZE Fat Loss (not what you think)

▶︎
Creatine for Women: Benefits, Safety, and How to Take It Right | Quick & Dirty EP. 203

▶︎
